Study on the efficacy and safety of fexofenadine hydrochloride capsules in patients with chronic idiopathic urticaria
Duo Gao
Abstract
Duo Gao
Abstract
Objective: To study the efficacy and safety of fexofenadine hydrochloride capsules versus cetirizine capsules in patients with chronic idiopathic urticaria.Methods: A Multicenter double-blind double-dummy comparative study of the efficacy and safety of fexofenadine hydrochloride capsules versus cetirizine capsules in patients with chronic idiopathic urticaria(phase Ⅱ).Results: 136 cases were accomplished,67 cases in tset group and 69 cases in control group.The effective rate of test group was 80.597%,that of control group was 71.014%.The two groups were not significantly different,P 0.05.The incidence of adverse drug reaction in test group was 11.429%,that of control group was 18.310%.The two groups were not significantly different,P 0.05.Conclusion: The efficacy and safety of fexofenadine hydrochloride capsules in patients with chronic idiopathic urticaria correspond to cetirizine capsules.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the efficacy and safety of fexofenadine hydrochloride capsules versus cetirizine capsules in patients with chronic idiopathic urticaria.Methods: A Multicenter double-blind double-dummy comparative study of the efficacy and safety of fexofenadine hydrochloride capsules versus cetirizine capsules in patients with chronic idiopathic urticaria(phase Ⅱ).Results: 136 cases were accomplished,67 cases in tset group and 69 cases in control group.The effective rate of test group was 80.597%,that of control group was 71.014%.The two groups were not significantly different,P 0.05.The incidence of adverse drug reaction in test group was 11.429%,that of control group was 18.310%.The two groups were not significantly different,P 0.05.Conclusion: The efficacy and safety of fexofenadine hydrochloride capsules in patients with chronic idiopathic urticaria correspond to cetirizine capsules.
Key concepts: Medicine, Cetirizine, Fexofenadine, Chronic idiopathic urticaria, Incidence (geometry), Adverse effect, Gastroenterology, Internal medicine